ClinicalTrials.Veeva

Menu

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

C

C. R. Bard

Status

Completed

Conditions

Lung Tumor
Lung Cancer

Treatments

Device: ProGEL Pleural Air Leak Sealant with standard surgical closure
Device: ProGEL Pleural Air Leak Sealant without standard surgical closure
Other: Control

Study type

Interventional

Funder types

Industry

Identifiers

NCT01394978
NEO09-100

Details and patient eligibility

About

The purpose of this post approval study is to further characterize the safety profile of the ProGEL™ Pleural Air Leak Sealant in commercial use, with specific reference to long-term safety over 90 days of follow-up.

Full description

Patients having open thoracotomy involving lung resection surgery will be considered for the study. Subjects will be examined for adverse events and complications from either the treatment or the procedure. Follow-up visits are required at 30 days and 90 days after the surgery.

Enrollment

444 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled for an open thoracotomy for lung resection
  • Has at least one or more intraoperative visible air leak >= 2 mm following the lung resection surgery

Exclusion criteria

  • Pregnant or breast feeding
  • History of an allergic reaction to Human Serum Albumin
  • Has a significant clinical disease or condition
  • Had previous open thoracotomy procedures
  • Unable to participate in all necessary study activities due to physical or mental limitations

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

444 participants in 3 patient groups

Control
Other group
Description:
No treatment.
Treatment:
Other: Control
ProGEL Pleural Air Leak Sealant with standard surgical closure
Experimental group
Description:
Standard surgical closure (suturing or stapling of visible air leaks incurred during resection of lung parenchyma) plus Progel Pleural Air Leak Sealant.
Treatment:
Device: ProGEL Pleural Air Leak Sealant with standard surgical closure
ProGEL Pleural Air Leak Sealant without standard surgical closure
Experimental group
Description:
Progel Pleural Air Leak Sealant without standard surgical closure (without suturing or stapling of visible air leaks incurred during resection of lung parenchyma).
Treatment:
Device: ProGEL Pleural Air Leak Sealant without standard surgical closure

Trial contacts and locations

18

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems